Carbylan Therapeutics, Inc. — Form D

Carbylan Therapeutics, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-14. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
TIMOTHY L TRAPPExecutive OfficerPALO ALTO, CA
Chris EhrlichDirectorSouth San Francisco, CA
Keith A KatkinDirectorSan Diego, CA
STEVEN BASTADirectorBRIDGEWATER, NJ
Mark WeeksExecutive OfficerMENLO PARK, CA
Albert ChaDirectorPALO ALTO, CA
Guy NohraDirectorSan Clemente, CA
Albert L ChaDirectorMenlo Park, CA
Steven L BastaDirectorMenlo Park, CA
DAVID W CLAPPERDirectorPALO ALTO, CA
EDWARD W UNKARTDirectorPALO ALTO, CA
MARCEE M MARONEYExecutive OfficerPALO ALTO, CA
DAVID M GRAVETTExecutive OfficerPALO ALTO, CA
T. MICHAEL WHITEExecutive OfficerPALO ALTO, CA
REZA P ZADNODirectorPALO ALTO, CA
HAYLEY M LEWISExecutive OfficerPALO ALTO, CA
DAVID M RENZIDirectorPALO ALTO, CA
DAVID M RENZIExecutive OfficerPALO ALTO, CA
Guy P NohraDirectorSan Francisco, CA
Marcee MaroneyExecutive OfficerPalo Alto, CA
Roxanne DuboisExecutive OfficerPalo Alto, CA
David GravettExecutive OfficerPalo Alto, CA
George DaniloffDirectorPalo Alto, CA
George DaniloffExecutive OfficerPalo Alto, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2015-03-05D$4.0M$4.0M
2013-01-03D$13.2M$6.0M

More